Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
9.39M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
8.54M
-
Shares change
-
-366K
-
Total reported value, excl. options
-
$285M
-
Value change
-
-$12.4M
-
Number of buys
-
31
-
Number of sells
-
-22
-
Price
-
$33.42
Significant Holders of Korro Bio, Inc. - Common stock, par value $0.001 per share (KRRO) as of Q3 2024
77 filings reported holding KRRO - Korro Bio, Inc. - Common stock, par value $0.001 per share as of Q3 2024.
Korro Bio, Inc. - Common stock, par value $0.001 per share (KRRO) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.54M shares
of 9.39M outstanding shares and own 90.91% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (1.14M shares), NEA Management Company, LLC (1.09M shares), Deep Track Capital, LP (850K shares), FMR LLC (580K shares), CITADEL ADVISORS LLC (529K shares), BlackRock, Inc. (450K shares), Point72 Asset Management, L.P. (445K shares), VANGUARD GROUP INC (437K shares), Siren, L.L.C. (419K shares), and EVENTIDE ASSET MANAGEMENT, LLC (391K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.